The reduced anti-cancer effect (ability to control the tumor growth) observed in mice treated with ONCOS-210 (2.5 × 106 VP/tumor treatment) might be related to lower expression of encoded transgene such as PADI1 (Figure S1), which presumably relates to low virus dose used in the study (2.5 × 106 VP/tumor). This evidence concerns the gene PADI1 and cancer.